Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other Non-Current Assets (2016 - 2025)

Integra Lifesciences Holdings' Other Non-Current Assets history spans 17 years, with the latest figure at $37.9 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 43.05% year-over-year to $37.9 million; the TTM value through Dec 2025 reached $37.9 million, down 43.05%, while the annual FY2025 figure was $37.9 million, 43.05% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $37.9 million at Integra Lifesciences Holdings, down from $42.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $77.9 million in Q3 2023 and bottomed at $16.4 million in Q4 2021.
  • The 5-year median for Other Non-Current Assets is $54.0 million (2024), against an average of $51.5 million.
  • The largest annual shift saw Other Non-Current Assets skyrocketed 247.87% in 2022 before it tumbled 43.05% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $16.4 million in 2021, then surged by 247.87% to $57.2 million in 2022, then rose by 1.76% to $58.2 million in 2023, then increased by 14.3% to $66.5 million in 2024, then crashed by 43.05% to $37.9 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Other Non-Current Assets are $37.9 million (Q4 2025), $42.2 million (Q3 2025), and $46.2 million (Q2 2025).